Patient characteristics, valve surgery and 1-year mortality in left-sided Staphylococcus aureus infective

Sikander Tajik Nielsen1, Peter Laursen Graversen2, Katra Hadji-Turdeghal2

  • 1Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Capital Region of Denmark, Denmark sikander.tajik.nielsen.02@regionh.dk.

PubMed

Insights

Surgery for Staphylococcus aureus infective endocarditis (SA-IE) was associated with lower 1-year mortality, but not significantly different in-hospital mortality. Patient characteristics and disease severity varied between surgical and non-surgical groups.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Surgical Outcomes

Background:

  • Staphylococcus aureus infective endocarditis (SA-IE) has high mortality rates (30-40%).
  • Guidelines suggest surgery for SA-IE, but comparative outcome data are limited.
  • Lack of robust evidence hinders definitive treatment strategy selection.

Purpose of the Study:

  • To compare outcomes between surgical and non-surgical treatment for left-sided SA-IE.
  • To analyze in-hospital and 1-year mortality in SA-IE patients.
  • To evaluate the impact of surgical intervention on SA-IE patient survival.

Main Methods:

  • Retrospective cohort study using the Danish endocarditis registry (2016-2021).
  • Identified 918 patients with left-sided SA-IE, categorized into surgical (17%) and non-surgical (83%) groups.
  • Analyzed baseline characteristics and mortality using Cox regression.

Main Results:

  • Surgical patients were younger, had fewer comorbidities but presented with more severe disease (larger vegetations, sepsis, emboli).
  • Crude in-hospital mortality was lower in the surgical group (17% vs. 28%).
  • Adjusted in-hospital mortality showed no significant difference, but 1-year mortality was significantly lower in surgical patients (HR 0.61).

Conclusions:

  • Surgical intervention for SA-IE was linked to reduced 1-year mortality.
  • Despite initial disease severity, surgical patients experienced better long-term survival.
  • Heterogeneity in patient populations limits definitive conclusions on treatment superiority.
Abstract

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
371
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
200
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
381
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
420
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
224
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
442